Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | MET | P08581 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL76389 | 0.78 | ALDH1A1 (0.44) | MAPTSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL17014578 | 0.77 | ALDH1A1 (0.43) | MAPTSMN1; SMN2NPC1LMNARAB9A | |
| SCHEMBL2140937 | 0.76 | ALDH1A1 (0.40) | MAPTSMN1; SMN2RECQLCA12CA1 | |
| SCHEMBL16658500 | 0.76 | ALDH1A1 (0.42) | MAPTSMN1; SMN2LMNATNFKDM4E | |
| SCHEMBL2733775 | 0.76 | CYP11B1 (0.51) | MAPTSMN1; SMN2RAB9ATNFKDM4E | |
| SCHEMBL2158220 | 0.75 | ALDH1A1 (0.47) | MAPTSMN1; SMN2RAB9ATNFKDM4E | |
| SCHEMBL2734767 | 0.75 | BIRC5 (0.47) | METCA12CA1CA2CA9 | |
| SCHEMBL2734772 | 0.74 | TNF (0.44) | MAPTSMN1; SMN2NPC1LMNARECQL | |
| SCHEMBL24067936 | 0.74 | CDK4 (0.39) | MAPTMETCA12CA1CA2 | |
| SCHEMBL17014583 | 0.74 | PIK3CA (0.40) | MAPTLMNARECQLMETKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10680182-B2 | Fluoranthene compound, and organic electronic device comprising same | LG CHEM, LTD. (KR) | 2020-06-09 | — | — | US | disclosed |
| EP-2924020-B1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2019-01-16 | — | — | EP | disclosed |
| EP-2924020-A1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2015-09-30 | — | — | EP | disclosed |
| US-20150236273-A1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2015-08-20 | — | — | US | disclosed |
| US-20150236273-A1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10680182-B2 | Fluoranthene compound, and organic electronic device comprising same | AFF2, ESR1, AFF4 | MAPT 957/4885SMN1; SMN2 387/4885NPC1 3434/4885 |
| US-20150236273-A1 | FLUORANTHENE COMPOUND, AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | AFF2, ESR1, AFF4 | MAPT 957/4885SMN1; SMN2 387/4885NPC1 3434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.